{"title":"Carissa caranda . L.叶片平喘活性的评价","authors":"A. Yadav, R. Vishwakarma, A. Jain","doi":"10.31024/apj.2019.4.4.2","DOIUrl":null,"url":null,"abstract":"The most common respiratory disease is asthma and it is the chronic condition, tedious to cure. 17-18 million people in United States are being affected by Asthma and in the last 20 years it is found to be increased about 75 %. As per the current status of asthma patients about 1 out of 13 children and 1 out of 20 adults are suffering from Asthma. It has been found that since 1980 number of cases of Asthma was increased for the children under the age of 5 years this alarming fact cannot be ignored. Children in school age 75% has captured by Asthma. 15-20 million asthmatic patients are estimated only in India. Data of death because of Asthma from developed countries reveals that the rate varies from 0.2-0.8 per 100,000 persons aged 6-35 (Nichols and Longworth, 1995). Symptomatic relief is pointing requirement for curing the attack of asthma by Ayurveda, Unani and traditional system. One of the most elite plants is mentioned in Ayurveda and Unani system for the treatment of Asthma (Shukla et al., 2011; Nichols et al., 1995).","PeriodicalId":7190,"journal":{"name":"Advance Pharmaceutical Journal","volume":"56 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Assessment of antiasthmatic activity of Carissa carandas L. leaves\",\"authors\":\"A. Yadav, R. Vishwakarma, A. Jain\",\"doi\":\"10.31024/apj.2019.4.4.2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The most common respiratory disease is asthma and it is the chronic condition, tedious to cure. 17-18 million people in United States are being affected by Asthma and in the last 20 years it is found to be increased about 75 %. As per the current status of asthma patients about 1 out of 13 children and 1 out of 20 adults are suffering from Asthma. It has been found that since 1980 number of cases of Asthma was increased for the children under the age of 5 years this alarming fact cannot be ignored. Children in school age 75% has captured by Asthma. 15-20 million asthmatic patients are estimated only in India. Data of death because of Asthma from developed countries reveals that the rate varies from 0.2-0.8 per 100,000 persons aged 6-35 (Nichols and Longworth, 1995). Symptomatic relief is pointing requirement for curing the attack of asthma by Ayurveda, Unani and traditional system. One of the most elite plants is mentioned in Ayurveda and Unani system for the treatment of Asthma (Shukla et al., 2011; Nichols et al., 1995).\",\"PeriodicalId\":7190,\"journal\":{\"name\":\"Advance Pharmaceutical Journal\",\"volume\":\"56 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advance Pharmaceutical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31024/apj.2019.4.4.2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advance Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31024/apj.2019.4.4.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
最常见的呼吸系统疾病是哮喘,它是一种慢性疾病,治疗起来很繁琐。在美国,有1700万到1800万人受到哮喘的影响,在过去的20年里,哮喘患者的数量增加了75%。根据哮喘患者的现状,每13名儿童中就有1名患有哮喘,每20名成年人中就有1名患有哮喘。据发现,自1980年以来,5岁以下儿童患哮喘的人数有所增加,这一令人震惊的事实不容忽视。75%的学龄儿童患有哮喘,估计仅在印度就有1500万至2000万哮喘患者。来自发达国家的哮喘病死亡数据显示,6-35岁人群的死亡率为每10万人0.2-0.8人(Nichols和Longworth, 1995年)。缓解症状是阿育吠陀、乌纳尼和传统系统治疗哮喘发作的指向要求。在阿育吠陀和乌纳尼治疗哮喘的系统中提到了最优秀的植物之一(Shukla等人,2011;Nichols et al., 1995)。
Assessment of antiasthmatic activity of Carissa carandas L. leaves
The most common respiratory disease is asthma and it is the chronic condition, tedious to cure. 17-18 million people in United States are being affected by Asthma and in the last 20 years it is found to be increased about 75 %. As per the current status of asthma patients about 1 out of 13 children and 1 out of 20 adults are suffering from Asthma. It has been found that since 1980 number of cases of Asthma was increased for the children under the age of 5 years this alarming fact cannot be ignored. Children in school age 75% has captured by Asthma. 15-20 million asthmatic patients are estimated only in India. Data of death because of Asthma from developed countries reveals that the rate varies from 0.2-0.8 per 100,000 persons aged 6-35 (Nichols and Longworth, 1995). Symptomatic relief is pointing requirement for curing the attack of asthma by Ayurveda, Unani and traditional system. One of the most elite plants is mentioned in Ayurveda and Unani system for the treatment of Asthma (Shukla et al., 2011; Nichols et al., 1995).